Revolution Medicines price target raised to $230 from $220 at Evercore ISI
bullish
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
bullish
What happened, with direct paths to the underlying reporting
Evercore ISI raises RVMD target to $230; posted price $201.19; priceChangeSinceSignal -1.21.
Target: $230
Posted price: $201.19
Analyst firm: Evercore ISI
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.